SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-071749
Filing Date
2023-12-20
Accepted
2023-12-20 08:40:16
Documents
14
Period of Report
2023-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-20231219.htm   iXBRL 8-K 54232
2 EX-99.1 sndx-ex99_1.htm   iXBRL EX-99.1 16161
3 GRAPHIC img199102934_0.jpg GRAPHIC 4902
  Complete submission text file 0000950170-23-071749.txt   224580

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sndx-20231219.xsd EX-101.SCH 2468
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sndx-20231219_lab.xml EX-101.LAB 20134
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sndx-20231219_pre.xml EX-101.PRE 12428
8 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20231219_htm.xml XML 5680
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 231499465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)